Testing pain causes and treatments in people with HIV
Part of Pain clinical trials.
This study looks at why chronic widespread pain happens in people with HIV and tests new ways to understand and treat it. You may be able to join if your HIV is stable on treatment and you meet pain and safety requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed HIV diagnosis, and you are a current patient in the UAB 1917 HIV Clinic
- You are between 19 and 65 years old
- You are taking HIV medicine (antiretroviral therapy) that has been stable (no major changes recently)
- You have chronic widespread pain (or, if you do not have HIV, you meet specific pain frequency rules for at least 3 months)
- You do not have certain blood, infection, autoimmune, or nervous system problems
- Your blood pressure, diabetes control, and mental health safety screening must be acceptable for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a low dose of naltrexone can reduce long-lasting nerve-related pain in adults living with HIV. It may help if your pain has been ongoing and you have stable HIV control.
This study looks at how stress affects pain in people with HIV. It may help find better ways to manage pain in this group.
This study tests if using a virtual reality (VR) headset for self-hypnosis can help people with HIV manage chronic pain. You would practice at home with a smartphone app, and researchers will track your pain levels over time.
This study tests a healthy behaviors program to help prevent insomnia in people with HIV who also have ongoing pain. If you have trouble sleeping and chronic pain, this program may help improve your sleep and well-being.
This study looks at whether changing where you get your HIV injection (in the buttock area) and using a virtual reality headset during the shot can reduce pain. It is for people whose HIV is well-controlled with the injectable medicines cabotegravir and rilpivirine.
This study tests whether personalized music therapy, delivered through your smartphone, can help reduce chronic pain in people living with HIV. You'll listen to music tailored to your preferences and track your pain levels.
Hear when a new Chronic Widespread Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.